India  

Bharat Biotech applies for WHO approval, pre-submission meeting soon

DNA Monday, 24 May 2021
It will have to now go through 3 more stages--pre-submission meeting, dossier accepted for review and the final status of assessment.
0
shares
ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Brazil's Anvisa provisionally suspends authorisation for exceptional import of 4 million Covaxin doses

After closing the emergency use authorisation (EUA) and Phase-3 clinical trials requests for Bharat Biotech’s Covaxin, Brazil’s health regulator Anvisa..
IndiaTimes

After suspending Covaxin clinical trials, Brazil closes EUA request

After suspending the clinical trials of Covaxin following the termination of Bharat Biotech's MoU with its Brazilian partner Precisa Medicamentos, Brazil’s..
IndiaTimes

Bharat Biotech commits to supply 500 million doses of Covaxin to Centre for immunisation programme

Bharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation..
IndiaTimes

World Health Organization World Health Organization Specialized agency of the United Nations

World Health Organisation calls for greater regulation to protect children from 'harmful' e-cigarettes

The head of the World Health Organisation has branded electronic cigarettes "harmful" as he warned their use should be better regulated to protect children and..
Sky News
WHO Europe Chief Kluge calls for a greater vaccination push [Video]

WHO Europe Chief Kluge calls for a greater vaccination push

Global Conversation speaks to Hans Kluge at the Mental Health Summit in Athens about the impact of the COVID-19 pandemic

Credit: Euronews English    Duration: 07:59Published
China opposes WHO's plan for a second phase of investigation on the origins of Covid | Oneindia News [Video]

China opposes WHO's plan for a second phase of investigation on the origins of Covid | Oneindia News

Today, China rejected the second phase of an investigation into the origin of the coronavirus by the World Health Organization. The WHO this month proposed a second phase of studies into the origins of the coronavirus in China. #China #CovidOrigin #WHO

Credit: Oneindia    Duration: 02:00Published

China shuts down city of 9.3 million over 17 COVID cases - as it rejects call for Wuhan lab investigation

China has shut down a city of 9.3 million people over 17 COVID-19 infections, while a proposed second phase of a World Health Organization (WHO) investigation..
Sky News

You Might Like